.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Chubb
Fish and Richardson
Boehringer Ingelheim
US Army
Moodys
Accenture
UBS
Federal Trade Commission

Generated: July 22, 2017

DrugPatentWatch Database Preview

Phenylbutazone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phenylbutazone and what is the scope of phenylbutazone freedom to operate?

Phenylbutazone
is the generic ingredient in three branded drugs marketed by Ivax Pharms, Novartis, Sandoz, Watson Labs, Sanofi Aventis Us, and Sun Pharm Inds, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for phenylbutazone.

Summary for Generic Name: phenylbutazone

Tradenames:3
Patents:1
Applicants:6
NDAs:11
Drug Master File Entries: see list9
Bulk Api Vendors: see list65
Clinical Trials: see list1
Patent Applications: see list8,212
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenylbutazone at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
PHENYLBUTAZONE
phenylbutazone
TABLET;ORAL088863-001Dec 4, 1985DISCNNoNo► Subscribe► Subscribe
Novartis
BUTAZOLIDIN
phenylbutazone
TABLET;ORAL008319-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Novartis
BUTAZOLIDIN
phenylbutazone
CAPSULE;ORAL008319-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
PHENYLBUTAZONE
phenylbutazone
TABLET;ORAL087674-001Apr 21, 1982DISCNNoNo► Subscribe► Subscribe
Sandoz
PHENYLBUTAZONE
phenylbutazone
TABLET;ORAL084339-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Chinese Patent Office
Boehringer Ingelheim
Fish and Richardson
Cipla
Cerilliant
Johnson and Johnson
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot